Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder

Major depressive disorder (MDD) contributes to a significant worldwide disease burden, expected to be second only to heart disease by 2050. However, accurate diagnosis has been a historical weakness in clinical psychiatry. As a result, there is a demand for diagnostic modalities with greater objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Juan Joseph, Silber, Tim, Bruno, Davide, Galatzer-Levy, Isaac Robert, Pomara, Nunzio, Marmar, Charles Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843170/
https://www.ncbi.nlm.nih.gov/pubmed/27199779
http://dx.doi.org/10.3389/fpsyt.2016.00072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843170/
https://www.ncbi.nlm.nih.gov/pubmed/27199779
http://dx.doi.org/10.3389/fpsyt.2016.00072

Ejemplares similares